HarmonyRx Appoints Daniel Frisbie as Chief Financial Officer

HarmonyRx, a transparent, clinically driven pharmacy benefits organization, has appointed Daniel Frisbie as its new Chief Financial Officer. The move comes as the company continues to expand its focus on delivering a more transparent and clinically focused approach to pharmacy benefit management.

Frisbie brings extensive experience in public accounting, financial reporting, technical accounting, internal controls, risk management, and process development. Prior to joining HarmonyRx, he served as a Senior Manager in EY's external audit practice, where he honed his skills in navigating complex financial environments and guiding organizations in maintaining disciplined financial and operational processes.

Joseph N. Savasta, CEO of HarmonyRx, expressed excitement about Frisbie's appointment.

Frisbie will lead the company's financial strategy, accounting operations, financial planning, and reporting. He will work closely with HarmonyRx's executive leadership team to provide financial insights that support strategic decision-making, operational efficiency, and sustainable growth. His appointment further strengthens the company's leadership team as HarmonyRx expands its approach to transparent, clinically focused pharmacy benefit management.

Frisbie is a Certified Public Accountant and is trained and certified in Lean Six Sigma principles, bringing an additional focus on process improvement, efficiency, and scalability to his role. He holds bachelor's degrees in accounting and finance from Temple University.

With a 100% pass-through model, hands-on clinical oversight, and a commitment to aligning decisions with the best interests of clients and members, HarmonyRx helps plan sponsors better manage pharmacy spend without losing sight of quality care. Privately held and independent, HarmonyRx combines sophisticated technology with responsive, high-touch service to deliver greater clarity, accountability, and long-term value.